This trial is exploring the correlation between a patient's peak tidal inspiratory flow pre and post extubation, as well as their response to different high-flow nasal cannula flows.
1 Primary · 2 Secondary · Reporting Duration: 20 minutes after each flow setting
Active Control
Experimental Treatment
28 Total Participants · 4 Treatment Groups
Primary Treatment: HFNC flow set at 2 times of patient peak tidal inspiratory flow · No Placebo Group · N/A
Age 18 - 90 · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: